Skip to Content

NVR RIC (Kisqali 200 mg)

Generic Name: ribociclib

Pill with imprint NVR RIC is Purple, Round and has been identified as Kisqali 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Kisqali is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Kisqali 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR RIC

Kisqali

Generic Name:
ribociclib
Imprint:
NVR RIC
Strength:
200 mg
Color:
Purple
Shape:
Round
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0874

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide